Global Technologies LTD

Global Technologies Ltd. is a U.S.-based holding company that operates through subsidiaries focused on health and wellness distribution, advisory services, and a recently de-emphasized EV infrastructure venture. The company has been repositioning its portfolio toward consumer-facing pharmaceutical sales and related commercialization models while limiting further capital commitment to GOe3 and the EV charging sector.

100,0 %

−32,8 %

+117,4 %

0.06

0.06

— Global Technologies LTD
%
Pharmaceutical supply and distribution45% Wholesale and distribution activities tied to pharmaceutical products and clinic-facing supply channels.
Sales agency and commissions20% Non-exclusive sales-agent arrangements that earn commissions by facilitating product sales.
Advisory and marketing services20% Consulting, marketing, and business development services delivered through GTLL Advisory.
Direct-to-consumer pharmaceutical commerce10% Emerging consumer-facing sales channel being built to replace paused wholesale GLP-1 activity.
EV infrastructure and other legacy initiatives5% GOe3-related EV charging and other legacy activities that are being deemphasized.

The company serves healthcare and wellness participants, including clinics, providers, partner pharmacies, and...

  • Healthcare clinics and providersprimary

    Buy pharmaceutical products and related supply services for patient treatment and clinic operations.

  • Wellness clinics and medical spasprimary

    Purchase advisory, marketing, and commercialization support to attract patients and improve sales.

  • Partner pharmacies and pharmaceutical supplierssecondary

    Use the company as a sales and distribution intermediary to reach end customers and generate volume.

  • Direct consumersemerging

    Targeted for DTC pharmaceutical sales as the company shifts away from the paused wholesale channel.

  • Third-party contractors and channel partnerssecondary

    Support execution of sales, fulfillment, and profit-sharing arrangements across the platform.

Global Technologies is incorporated in Delaware and operates from Greensboro, North Carolina, with a business footprint...

  • Headquartered in Greensboro, North Carolina
  • Incorporated in Delaware and managed as a U.S. public company
  • Operations are primarily U.S.-based and regulation-driven
  • No country revenue split was disclosed in the excerpts
  • Macro exposure includes supply chains, trade, and capital markets

Management is reallocating resources toward sectors with clearer demand and monetization paths, especially...

01
Build a compliant direct-to-consumer pharmaceutical platformshort-term

The wholesale channel was disrupted by FDA-related rulings, so DTC is the main path to restore growth.

02
Monetize customer data and engagement capabilitiesmedium-term

A data repository can improve targeting, conversion, and client outcomes across sales and advisory efforts.

03
Preserve capital and reduce exposure to EV infrastructureshort-term

GOe3 and the EV charging market appear less attractive due to saturation and consolidation.

04
Secure external funding and strategic partnershipsshort-term

The company has limited resources and needs financing to support operations and the pivot.

The company faces substantial going-concern and liquidity risk because it has limited financial resources, accumulated...

critical

Going-concern and liquidity shortfall

The company reports limited financial resources, accumulated deficit, and substantial doubt about its ability to continue.

Scope
Operating funding, supplier payments, and growth investment
Materiality
high
high

Regulatory disruption in pharmaceutical sales

FDA and state oversight can pause or restrict product channels, as seen in the GLP-1 wholesale disruption.

Scope
Primecare Supply and DTC pharmaceutical sales
Materiality
high
high

Competitive pressure from larger and better-capitalized rivals

Competitors may have stronger brands, broader networks, and more resources to win customers.

Scope
Distribution, advisory, and wellness clinic channels
Materiality
medium
medium

Cybersecurity and data privacy exposure

The business relies on customer data, engagement systems, and sensitive healthcare-related information.

Scope
Marketing, CRM, and consumer-facing sales operations
Materiality
medium
medium

Macroeconomic and geopolitical uncertainty

Inflation, supply-chain issues, and geopolitical tensions can slow spending and disrupt sourcing.

Scope
Customer demand, supplier availability, and capital access
Materiality
medium
Derivative liability valuation
Earnings volatility and balance sheet measurement
Restatement and acquisition accounting
Comparability and asset basis
Impairment and write-offs
Asset values and operating results
Revenue recognition for commissions and profit-sharing
Revenue and gross margin presentation
Going-concern assessment
Disclosure risk and financing assumptions

: 28/04/2026